Chemotherapy Induces Cancer-Fighting B Cells

Cell. 2020 Mar 19;180(6):1037-1039. doi: 10.1016/j.cell.2020.02.046. Epub 2020 Mar 5.

Abstract

Tumor-infiltrating B cells are heterogeneous, and their roles in tumor immunity are controversial. In this issue of Cell, Lu and colleagues demonstrate that chemotherapy-induced complement signals promote the generation of ICOSL+B cells, which enhance tumor-specific T cell responses.

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents*
  • B-Lymphocytes
  • Humans
  • Neoplasms*
  • T-Lymphocytes

Substances

  • Antineoplastic Agents